MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients

MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients

Conditions: Type 2 Diabetes; Medication Adherence; Care Transition; Medication Discrepancy
Interventions: Behavioral: MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention
Sponsors: University of Alabama at Birmingham
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 21, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments